{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:10:45Z","timestamp":1757621445503,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.urolonc.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:15:41Z","timestamp":1753874141000},"page":"598.e17-598.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the uptake of core outcome sets in randomized controlled trials for localized prostate cancer: A cross-sectional study"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-6267","authenticated-orcid":false,"given":"Carson L.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Magana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaelyn","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griffin","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Ito-Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.07.008_bib0001","unstructured":"Prostate cancer\u2014patient version. National Cancer Institute. https:\/\/www.cancer.gov\/types\/prostate. Accessed July 10, 2023"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0002","article-title":"Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.urolonc.2025.07.008_bib0003","first-page":"264","article-title":"Screening for prostate cancer","volume":"59","author":"Brawley","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.urolonc.2025.07.008_bib0004","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1464-410X.2011.10365.x","article-title":"The economic burden of prostate cancer","volume":"108","author":"Roehrborn","year":"2011","journal-title":"BJU Int"},{"issue":"17","key":"10.1016\/j.urolonc.2025.07.008_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174088","article-title":"The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments","volume":"14","author":"Cantarero-Prieto","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.urolonc.2025.07.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221775","article-title":"Global incidence of prostate cancer in developing and developed countries with changing age structures","volume":"14","author":"Teoh","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.urolonc.2025.07.008_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021796","article-title":"Reporting of outcomes in gastric cancer surgery trials: a systematic review","volume":"8","author":"Alkhaffaf","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146444","article-title":"Choosing important health outcomes for comparative effectiveness research: an updated review and user survey","volume":"11","author":"Gorst","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.urolonc.2025.07.008_bib0009","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"5B","key":"10.1016\/j.urolonc.2025.07.008_bib0010","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1111\/bju.13854","article-title":"A core outcome set for localised prostate cancer effectiveness trials","volume":"120","author":"MacLennan","year":"2017","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.urolonc.2025.07.008_bib0011","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1183\/13993003.02049-2015","article-title":"Defining a standard set of patient-centred outcomes for lung cancer","volume":"48","author":"Mak","year":"2016","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.urolonc.2025.07.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002447","article-title":"Core outcome set-STAndards for development: the COS-STAD recommendations","volume":"14","author":"Kirkham","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jclinepi.2020.09.029","article-title":"A systematic review finds Core Outcome Set uptake varies widely across different areas of health","volume":"129","author":"Hughes","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jclinepi.2022.06.016","article-title":"Review finds core outcome set uptake in new studies and systematic reviews needs improvement","volume":"150","author":"Williamson","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.07.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0016","doi-asserted-by":"crossref","first-page":"j2262","DOI":"10.1136\/bmj.j2262","article-title":"A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.Gov: findings from a review of randomised controlled trials of rheumatoid arthritis","volume":"357","author":"Kirkham","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0017","unstructured":"Magee T, Jones G, Magana K, Fitzgerald K, Modi J, Ward S OSF. https:\/\/osf.io\/s8zxw\/. Accessed July 13, 2023"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.008_bib0018","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13063-017-1870-2","article-title":"Why clinical trial outcomes fail to translate into benefits for patients","volume":"18","author":"Heneghan","year":"2017","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.urolonc.2025.07.008_bib0019","first-page":"196","article-title":"Management of complications of prostate cancer treatment","volume":"58","author":"Michaelson","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 5","key":"10.1016\/j.urolonc.2025.07.008_bib0020","first-page":"S37","article-title":"Adverse events associated with hormonal therapy for prostate cancer","volume":"7","author":"Kumar","year":"2005","journal-title":"Rev Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.07.008_bib0021","first-page":"186","article-title":"Urinary adverse effects of pelvic radiotherapy","volume":"3","author":"Liberman","year":"2014","journal-title":"Transl Androl Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.07.008_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","article-title":"Adverse event reporting in cancer clinical trial publications","volume":"32","author":"Sivendran","year":"2014","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.urolonc.2025.07.008_bib0023","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1002\/cam4.3095","article-title":"Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: a systematic review","volume":"9","author":"Komorowski","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.008_bib0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41391-022-00520-x","article-title":"Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis","volume":"26","author":"David","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.urolonc.2025.07.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003901","article-title":"Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates","volume":"4","author":"Watts","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.urolonc.2025.07.008_bib0026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ophtha.2018.09.008","article-title":"Choosing core outcomes for use in clinical trials in ophthalmology: perspectives from three ophthalmology outcomes working groups","volume":"126","author":"Saldanha","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.urolonc.2025.07.008_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222418","article-title":"Assessing the impact of a research funder\u2019s recommendation to consider core outcome sets","volume":"14","author":"Hughes","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0028","unstructured":"Redirecting. https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/media\/117792\/download&sa=D&source=docs&ust=1689704507403385&usg=AOvVaw0Frm_WyFpBErq45JNl1hqn. Accessed July 18, 2023"},{"issue":"5","key":"10.1016\/j.urolonc.2025.07.008_bib0029","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2022.01.042","article-title":"Updating and integrating core outcome sets for localised, locally advanced, metastatic, and nonmetastatic castration-resistant prostate cancer: an update from the PIONEER Consortium","volume":"81","author":"Beyer","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0030","unstructured":"CTG labs - NCBI. https:\/\/www.clinicaltrials.gov\/. Accessed July 20, 2023"},{"key":"10.1016\/j.urolonc.2025.07.008_bib0031","unstructured":"ICTRP search portal. https:\/\/www.who.int\/clinical-trials-registry-platform\/the-ictrp-search-portal. Accessed July 20, 2023"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925002625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:28:18Z","timestamp":1757338098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925002625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1078143925002625"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the uptake of core outcome sets in randomized controlled trials for localized prostate cancer: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}